Publication:
Linezolid Versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Keratitis in Rabbits

Simple item page
dc.contributor.authorTas, Tekin
dc.contributor.authorKucukbayrak, Abdulkadir
dc.contributor.authorHakyemez, Ismail N.
dc.contributor.authorMengeloglu, Firat Z.
dc.contributor.authorSIMAVLI, Huseyin
dc.contributor.authorOzyalvacli, Gulzade
dc.contributor.authorErdurmus, Mesut
dc.contributor.institutionauthorHAKYEMEZ, İSMAİL NECATİ
dc.date.accessioned2020-10-30T00:11:39Z
dc.date.available2020-10-30T00:11:39Z
dc.date.issued2013-07-01T00:00:00Z
dc.description.abstractPurpose: To compare the efficacy of topical linezolid (LZD) 1 mg/mL or 2 mg/mL to vancomycin (VA) 50 mg/mL for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) keratitis in rabbits.
dc.identifier.citationTas T., Kucukbayrak A., Hakyemez I. N. , Mengeloglu F. Z. , SIMAVLI H., Ozyalvacli G., Erdurmus M., -Linezolid Versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Keratitis in Rabbits-, CORNEA, cilt.32, ss.1052-1057, 2013
dc.identifier.doi10.1097/ico.0b013e3182912ffa
dc.identifier.scopus84879088024
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27116
dc.identifier.wosWOS:000330356600045
dc.titleLinezolid Versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Keratitis in Rabbits
dc.typeArticle
dspace.entity.typePublication
local.avesis.idead052a3-b78d-47bc-b3d7-f1c1f1eaa589
local.publication.isinternational1
relation.isAuthorOfPublication34a9d344-3a58-4f83-864a-5a5c664557bd
relation.isAuthorOfPublication.latestForDiscovery34a9d344-3a58-4f83-864a-5a5c664557bd
Files
Collections
Silinecekler